Some recent studies have indicated that miR-223-3p could down-regulate aNHEJ expression to result in synthetic lethality in human BRCA1-deficient cancers [65], and also act as an oncogenic miRNA in colon cancer through regulating EMT and PRDM1 [66]. The gene discussed is PRDM1; the disease is cancer.